STRO 10-Q: SEC filing

Sutro Biopharma

Filed with the SEC on · accession 0001193125-26-458680

STRO filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -6.5% by the first close after the filing.

Summary of the filing

Sutro Biopharma filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results and ongoing collaboration agreements with partners including Ipsen, Astellas, and Vaxcyte.

Key details

Collaboration and license partnerIpsen Pharma SAS
License and collaboration partnerAstellas
Collaboration and supply partnerVaxcyte, Inc.
License agreement counterpartyBlackstone Life Sciences

How STRO stock reacted

Close before

$10.26

Nov 11, 2026

First close after

-6.53%

$9.59

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for STRO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for STRO?

Click here

Frequently asked questions

What did STRO file with the SEC on Nov 12, 2026?

STRO filed a 10-Q (SEC filing). Sutro Biopharma filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results and ongoing collaboration agreements with partners including Ipsen, Astellas, and Vaxcyte.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did STRO stock react to this filing?

STRO closed at $10.26 before the filing and $9.59 on Nov 12, 2026 (-6.53%).

Other STRO SEC filings

Get alerts when STRO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days